Paula Soteropoulos Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paula Soteropoulos.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paula Soteropoulos. Paula Soteropoulos is Director in uniQure N.V. ($QURE) and Chief Executive Officer in AKCEA THERAPEUTICS, INC. ($AKCA) and President & CEO in AKCEA THERAPEUTICS, INC. ($AKCA).
Latest Insider Trading Transactions of Paula Soteropoulos
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2021 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Sell | S | 37.60 | 504 | 18,950 | 6,364 | 6.9 K to 6.4 K (-7.34 %) |
| Mar 01 2021 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Option Exercise | A | 37.00 | 4,107 | 151,959 | 4,107 | |
| Mar 01 2021 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Grant | A | 0.00 | 2,382 | 0 | 6,868 | 4.5 K to 6.9 K (+53.10 %) |
| Mar 02 2020 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Option Exercise | A | 51.81 | 3,620 | 187,552 | 3,620 | |
| Mar 02 2020 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Grant | A | 0.00 | 2,063 | 0 | 4,486 | 2.4 K to 4.5 K (+85.14 %) |
| Mar 02 2020 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Option Exercise | A | 51.81 | 3,620 | 187,552 | 3,620 | |
| Mar 02 2020 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Grant | A | 0.00 | 2,063 | 0 | 4,486 | 2.4 K to 4.5 K (+85.14 %) |
| Feb 05 2020 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Sell | S | 61.53 | 822 | 50,578 | 2,423 | 3.2 K to 2.4 K (-25.33 %) |
| Feb 05 2020 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Sell | S | 60.58 | 1,300 | 78,754 | 3,245 | 4.5 K to 3.2 K (-28.60 %) |
| Jan 30 2020 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Sell | S | 62.19 | 807 | 50,187 | 4,545 | 5.4 K to 4.5 K (-15.08 %) |
| Jan 08 2020 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Sell | S | 72.18 | 3,000 | 216,540 | 5,352 | 8.4 K to 5.4 K (-35.92 %) |
| Dec 17 2019 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Option Exercise | M | 5.37 | 2,000 | 10,740 | 9,000 | |
| Dec 17 2019 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Sell | S | 70.50 | 2,000 | 141,000 | 8,352 | 10.4 K to 8.4 K (-19.32 %) |
| Dec 17 2019 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Buy | M | 5.37 | 2,000 | 10,740 | 10,352 | 8.4 K to 10.4 K (+23.95 %) |
| Dec 09 2019 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Sell | S | 67.50 | 2,500 | 168,750 | 8,352 | 10.9 K to 8.4 K (-23.04 %) |
| Dec 09 2019 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Sell | S | 64.39 | 7,382 | 475,327 | 10,852 | 18.2 K to 10.9 K (-40.48 %) |
| Dec 09 2019 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Sell | S | 63.69 | 1,700 | 108,273 | 18,234 | 19.9 K to 18.2 K (-8.53 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 12.21 | 205,479 | 2,508,899 | 102,740 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 145,303 | 941,563 | 13,209 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 1,711,079 | 11,087,792 | 0 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Payment of Exercise | F | 16.64 | 175,064 | 2,913,065 | 678,149 | 853.2 K to 678.1 K (-20.52 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 12.21 | 205,479 | 2,508,899 | 853,213 | 647.7 K to 853.2 K (+31.72 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Payment of Exercise | F | 16.64 | 95,156 | 1,583,396 | 647,734 | 742.9 K to 647.7 K (-12.81 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 145,303 | 941,563 | 742,890 | 597.6 K to 742.9 K (+24.31 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Payment of Exercise | F | 16.64 | 1,113,492 | 18,528,507 | 597,587 | 1.7 M to 597.6 K (-65.08 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 1,711,079 | 11,087,792 | 1,711,079 | 0 to 1.7 M |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 1,787 | 11,580 | 1,711,079 | |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 30,000 | 194,400 | 1,712,866 | |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Sell | S | 32.17 | 1,787 | 57,480 | 0 | 1.8 K to 0 (-100.00 %) |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 1,787 | 11,580 | 1,787 | 0 to 1.8 K |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Sell | S | 32.11 | 30,000 | 963,300 | 0 | 30 K to 0 (-100.00 %) |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 30,000 | 194,400 | 30,000 | 0 to 30 K |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 1,787 | 11,580 | 1,711,079 | |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 30,000 | 194,400 | 1,712,866 | |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Sell | S | 32.17 | 1,787 | 57,480 | 0 | 1.8 K to 0 (-100.00 %) |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 1,787 | 11,580 | 1,787 | 0 to 1.8 K |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Sell | S | 32.11 | 30,000 | 963,300 | 0 | 30 K to 0 (-100.00 %) |
| Apr 09 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 30,000 | 194,400 | 30,000 | 0 to 30 K |
| Mar 07 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 18,386 | 119,141 | 1,742,866 | |
| Mar 07 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Sell | S | 32.14 | 18,386 | 590,856 | 0 | 18.4 K to 0 (-100.00 %) |
| Mar 07 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 18,386 | 119,141 | 18,386 | 0 to 18.4 K |
| Jan 30 2019 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Sell | S | 31.32 | 1,210 | 37,897 | 19,934 | 21.1 K to 19.9 K (-5.72 %) |
| Jan 29 2019 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Option Exercise | A | 31.71 | 5,295 | 167,904 | 5,295 | |
| Jan 29 2019 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Grant | A | 0.00 | 3,230 | 0 | 21,144 | 17.9 K to 21.1 K (+18.03 %) |
| Jan 04 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | A | 30.73 | 296,000 | 9,096,080 | 296,000 | |
| Jan 31 2018 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Sell | S | 18.53 | 2,878 | 53,329 | 17,914 | 20.8 K to 17.9 K (-13.84 %) |
| Jan 30 2018 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Option Exercise | A | 19.39 | 6,390 | 123,902 | 6,390 | |
| Jan 30 2018 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Grant | A | 0.00 | 4,792 | 0 | 20,792 | 16 K to 20.8 K (+29.95 %) |
| Jan 04 2018 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | President & CEO | Option Exercise | A | 17.38 | 275,000 | 4,779,500 | 275,000 | |
| Jan 31 2017 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Option Exercise | A | 0.00 | 11,000 | 0 | 16,000 | |
| Jan 31 2017 | QURE | uniQure N.V. | Soteropoulos Paula | Director | Option Exercise | A | 5.37 | 11,000 | 59,070 | 11,000 |
Page: 1